PL1928858T3 - Stałe postacie soli pirolo-podstawionego 2-indolinonu - Google Patents
Stałe postacie soli pirolo-podstawionego 2-indolinonuInfo
- Publication number
- PL1928858T3 PL1928858T3 PL06795470T PL06795470T PL1928858T3 PL 1928858 T3 PL1928858 T3 PL 1928858T3 PL 06795470 T PL06795470 T PL 06795470T PL 06795470 T PL06795470 T PL 06795470T PL 1928858 T3 PL1928858 T3 PL 1928858T3
- Authority
- PL
- Poland
- Prior art keywords
- indolinone
- salt forms
- solid salt
- pyrrole substituted
- pyrrole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71858605P | 2005-09-19 | 2005-09-19 | |
| PCT/IB2006/002506 WO2007034272A1 (en) | 2005-09-19 | 2006-09-08 | Solid salt forms of a pyrrole substituted 2-indolinone |
| EP06795470A EP1928858B1 (en) | 2005-09-19 | 2006-09-08 | Solid salt forms of a pyrrole substituted 2-indolinone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1928858T3 true PL1928858T3 (pl) | 2009-12-31 |
Family
ID=37626412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06795470T PL1928858T3 (pl) | 2005-09-19 | 2006-09-08 | Stałe postacie soli pirolo-podstawionego 2-indolinonu |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US20080275101A1 (pl) |
| EP (2) | EP1928858B1 (pl) |
| JP (2) | JP4519114B2 (pl) |
| KR (1) | KR101050906B1 (pl) |
| CN (2) | CN101287724B (pl) |
| AR (1) | AR056521A1 (pl) |
| AU (1) | AU2006293644B2 (pl) |
| BR (1) | BRPI0616374B8 (pl) |
| CA (1) | CA2621569C (pl) |
| CY (1) | CY1109326T1 (pl) |
| DE (1) | DE602006008015D1 (pl) |
| DK (1) | DK1928858T3 (pl) |
| ES (1) | ES2328407T3 (pl) |
| HK (1) | HK1125101A1 (pl) |
| IL (1) | IL189590A0 (pl) |
| MX (1) | MX2008002415A (pl) |
| NO (1) | NO20080866L (pl) |
| NZ (1) | NZ566033A (pl) |
| PL (1) | PL1928858T3 (pl) |
| PT (1) | PT1928858E (pl) |
| RU (1) | RU2399619C2 (pl) |
| SI (1) | SI1928858T1 (pl) |
| TW (1) | TWI310766B (pl) |
| WO (1) | WO2007034272A1 (pl) |
| ZA (1) | ZA200801431B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101050906B1 (ko) | 2005-09-19 | 2011-07-20 | 화이자 프로덕츠 인크. | 피롤 치환된 2-인돌리논의 고체 염 형태 |
| US20100189791A1 (en) | 2009-01-23 | 2010-07-29 | Teva Pharmaceutical Industries, Ltd. | Delayed release rasagiline malate formulation |
| WO2011110199A1 (en) | 2010-03-10 | 2011-09-15 | Synthon B.V. | A process for amidation of pyrrole carboxylate compounds |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6574293B1 (en) | 1998-10-28 | 2003-06-03 | Ericsson Inc. | Receivers and methods for reducing interference in radio communications |
| US20020010203A1 (en) * | 1999-12-22 | 2002-01-24 | Ken Lipson | Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| WO2001060814A2 (en) * | 2000-02-15 | 2001-08-23 | Sugen, Inc. | Pyrrole substituted 2-indolinone protein kinase inhibitors |
| WO2002081466A1 (en) * | 2001-04-09 | 2002-10-17 | Sugen, Inc. | Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| CA2455050C (en) * | 2001-08-15 | 2007-02-20 | Pharmacia & Upjohn Company | Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| CN1308326C (zh) * | 2002-02-15 | 2007-04-04 | 法马西亚和厄普乔恩公司 | 吲哚满酮衍生物的制备方法 |
| US7452913B2 (en) * | 2003-02-24 | 2008-11-18 | Pharmacia & Upjohn Company | Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| US20040209937A1 (en) * | 2003-02-24 | 2004-10-21 | Sugen, Inc. | Treatment of excessive osteolysis with indolinone compounds |
| US20060009510A1 (en) * | 2004-07-09 | 2006-01-12 | Pharmacia & Upjohn Company Llc | Method of synthesizing indolinone compounds |
| KR101050906B1 (ko) | 2005-09-19 | 2011-07-20 | 화이자 프로덕츠 인크. | 피롤 치환된 2-인돌리논의 고체 염 형태 |
-
2006
- 2006-09-08 KR KR1020087006545A patent/KR101050906B1/ko active IP Right Grant
- 2006-09-08 DE DE602006008015T patent/DE602006008015D1/de active Active
- 2006-09-08 US US12/067,242 patent/US20080275101A1/en not_active Abandoned
- 2006-09-08 SI SI200630386T patent/SI1928858T1/sl unknown
- 2006-09-08 PL PL06795470T patent/PL1928858T3/pl unknown
- 2006-09-08 AU AU2006293644A patent/AU2006293644B2/en active Active
- 2006-09-08 CN CN2006800345053A patent/CN101287724B/zh active Active
- 2006-09-08 CA CA2621569A patent/CA2621569C/en active Active
- 2006-09-08 WO PCT/IB2006/002506 patent/WO2007034272A1/en active Application Filing
- 2006-09-08 EP EP06795470A patent/EP1928858B1/en active Active
- 2006-09-08 CN CN201310478975.0A patent/CN103601720B/zh active Active
- 2006-09-08 DK DK06795470T patent/DK1928858T3/da active
- 2006-09-08 ES ES06795470T patent/ES2328407T3/es active Active
- 2006-09-08 BR BRPI0616374A patent/BRPI0616374B8/pt active IP Right Grant
- 2006-09-08 NZ NZ566033A patent/NZ566033A/en unknown
- 2006-09-08 EP EP09165944A patent/EP2112148A1/en not_active Withdrawn
- 2006-09-08 MX MX2008002415A patent/MX2008002415A/es active IP Right Grant
- 2006-09-08 PT PT06795470T patent/PT1928858E/pt unknown
- 2006-09-08 RU RU2008109959/04A patent/RU2399619C2/ru not_active IP Right Cessation
- 2006-09-15 JP JP2006250347A patent/JP4519114B2/ja active Active
- 2006-09-18 TW TW095134445A patent/TWI310766B/zh not_active IP Right Cessation
- 2006-09-19 AR ARP060104101A patent/AR056521A1/es not_active Application Discontinuation
-
2008
- 2008-02-18 NO NO20080866A patent/NO20080866L/no not_active Application Discontinuation
- 2008-02-18 IL IL189590A patent/IL189590A0/en unknown
- 2008-09-12 ZA ZA200801431A patent/ZA200801431B/xx unknown
-
2009
- 2009-03-16 HK HK09102463.5A patent/HK1125101A1/xx unknown
- 2009-08-20 CY CY20091100887T patent/CY1109326T1/el unknown
- 2009-12-10 JP JP2009279987A patent/JP2010090152A/ja active Pending
-
2012
- 2012-02-06 US US13/367,009 patent/US8987320B2/en active Active
-
2015
- 2015-02-12 US US14/620,835 patent/US9290479B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1931632A4 (en) | USEFUL INDOOR CONNECTIONS | |
| SI1919907T1 (sl) | Heterocikliäśna spojina | |
| ZA200709051B (en) | Heterocyclic compound | |
| EP2079466A4 (en) | SUBSTITUTED INDOLE COMPOUNDS | |
| EP2049520A4 (en) | indole compounds | |
| ZA200902585B (en) | Indole compound | |
| HK1123038A1 (en) | Heterocyclic compounds | |
| PT1882684E (pt) | Derivado de pirrolidina ou um seu sal | |
| IL191768A0 (en) | Novel fused pyrrole derivatives | |
| EP1841424A4 (en) | SYNTHESIS OF ARYL PYRROLIDONES | |
| IL195158A0 (en) | Novel heterocyclic compounds | |
| IL187279A0 (en) | Hydantoin compounds | |
| IL183647A (en) | The heterocyclic compounds are converted into 3-ethylidenehydrazino | |
| GB0504314D0 (en) | Novel polymorph | |
| ZA200900843B (en) | Indole compounds | |
| ZA200806256B (en) | Malononitrile compounds | |
| ZA200800142B (en) | Heterocyclic compound | |
| HK1125101A1 (en) | Solid salt forms of a pyrrole substituted 2-indolinone | |
| EP1961754A4 (en) | BICYCLIC HETEROCYCLIC COMPOUND | |
| IL186499A0 (en) | New crystalline atorvastatin hemicalcium salt polymorph form | |
| IL195061A0 (en) | Crystalline forms of atorvastatin | |
| ZA200803017B (en) | Heterocyclic compounds | |
| EP1986997A4 (en) | NEW CRYSTALLINE HEMI-CALCIUM FORM OF ATORVASTATIN | |
| GB0506967D0 (en) | Novel crystalline salt | |
| ZA200800488B (en) | New Salt III |